Pharmacokinetic, pharmacodynamic, and safety study of intravenous ganaxolone in healthy adult volunteers
Publication
, Conference
Barra, M; Vaitkevicius, H; Husain, A; Raja, S; MacLeod, D; Guptill, J; Hulihan, J; Gasior, M; Rybak, E
Published in: EPILEPSIA
2023
Duke Scholars
Published In
EPILEPSIA
EISSN
1528-1167
ISSN
0013-9580
Publication Date
2023
Volume
64
Start / End Page
178 / 179
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Barra, M., Vaitkevicius, H., Husain, A., Raja, S., MacLeod, D., Guptill, J., … Rybak, E. (2023). Pharmacokinetic, pharmacodynamic, and safety study of intravenous ganaxolone in healthy adult volunteers. In EPILEPSIA (Vol. 64, pp. 178–179).
Barra, M., H. Vaitkevicius, A. Husain, S. Raja, D. MacLeod, J. Guptill, J. Hulihan, M. Gasior, and E. Rybak. “Pharmacokinetic, pharmacodynamic, and safety study of intravenous ganaxolone in healthy adult volunteers.” In EPILEPSIA, 64:178–79, 2023.
Barra M, Vaitkevicius H, Husain A, Raja S, MacLeod D, Guptill J, et al. Pharmacokinetic, pharmacodynamic, and safety study of intravenous ganaxolone in healthy adult volunteers. In: EPILEPSIA. 2023. p. 178–9.
Barra, M., et al. “Pharmacokinetic, pharmacodynamic, and safety study of intravenous ganaxolone in healthy adult volunteers.” EPILEPSIA, vol. 64, 2023, pp. 178–79.
Barra M, Vaitkevicius H, Husain A, Raja S, MacLeod D, Guptill J, Hulihan J, Gasior M, Rybak E. Pharmacokinetic, pharmacodynamic, and safety study of intravenous ganaxolone in healthy adult volunteers. EPILEPSIA. 2023. p. 178–179.
Published In
EPILEPSIA
EISSN
1528-1167
ISSN
0013-9580
Publication Date
2023
Volume
64
Start / End Page
178 / 179
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences